Skip to main content

4 Result(s)

within Philippe Rougier Remove this filter Medicine/Public Health, general Remove this filter

and

  1. No Access

    Chapter

    Traitement des cancers digestifs du sujet âgé

    Les cancers digestifs surviennent dans la grande majorité des cas chez les patients âgés de plus de 65 ans. Compte tenu du vieillissement de la population, l’incidence des cancers digestifs chez les sujets âgé...

    Emmanuel Mitry, Thomas Aparicio, Philippe Rougier in Les cancers digestifs du sujet âgé (2010)

  2. Article

    Open Access

    Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

    The anti-VEGF antibody bevacizumab associated with an irinotecan or oxaliplatin-based chemotherapy was proved to be superior to the chemotherapy alone in first or second line treatment of metastatic colorectal...

    Astrid Lièvre, Emmanuelle Samalin, Emmanuel Mitry, Eric Assenat… in BMC Cancer (2009)

    Download PDF (752 KB) View Article

  3. Article

    Open Access

    Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

    This study was designed to investigate the efficacy and safety of the epidermal growth factor receptor (EGFR) inhibitor cetuximab combined with irinotecan, folinic acid (FA) and two different doses of infusion...

    Jean-Luc Raoul, Jean-Luc Van Laethem, Marc Peeters, Catherine Brezault… in BMC Cancer (2009)

    Download PDF (1030 KB) View Article

  4. No Access

    Article

    No evidence of somatic FGFR3 mutation in various types of carcinoma

    Germline specific point mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3) are associated with autosomal dominant human skeletal dysplasia and craniosynostosis syndromes. Mutations iden...

    Mehdi Karoui, Hélène Hofmann-Radvanyi, Ute Zimmermann, Anne Couvelard… in Oncogene (2001)